MTND1P32

Across TCGA pan-cancer cohorts, MTND1P32 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MTND1P32 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher MTND1P32 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTND1P32 expression acts as an unfavorable survival marker, although some lineages such as OV and BLCA show a favorable association.

UVM, OV, and LIHC are the cancer types where MTND1P32 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	All	0.349	0.731	.001	108	view →
OV	DFS	Tertile	III,IV	0.228	0.122	.002	74	view →
LIHC	DFS	Tertile	II,III,IV	0.183	0.446	.002	63	view →
THCA	DFS	Tertile	II,III,IV	0.496	0.785	<.001	48	view →
KICH	DFS	Tertile	III,IV	0.025	0.773	<.001	45	view →
BLCA	OS	Tertile	All	0.624	0.378	.007	42	view →
READ	DFS	Tertile	IV	0.141	0.671	<.001	42	view →
MESO	DFS	Tertile	All	0.258	0.421	.021	36	view →
ESCA	OS	Median	All	0.393	0.585	.002	26	view →
GBM	OS	Tertile	All	0.671	0.386	.015	21	view →
ACC	DFS	Tertile	III,IV	0.140	0.533	.002	18	view →
STAD	OS	Median	II,III,IV	0.700	0.435	.019	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MTND1P32–UVM (OS)

Open the UVM breakdown →